SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1987, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a diverse portfolio that includes anti-infectives, anti-diabetics, and cardiovascular medications, SMS Pharmaceuticals is recognised for its commitment to quality and innovation. The company’s state-of-the-art manufacturing facilities adhere to stringent regulatory standards, ensuring the delivery of high-quality products. Notable achievements include successful collaborations with global pharmaceutical firms and a strong market presence in Europe and the Americas. SMS Pharmaceuticals Ltd continues to drive advancements in healthcare, making significant contributions to the pharmaceutical landscape.
DitchCarbon Score
How does SMS Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SMS Pharmaceuticals Ltd's score of 32 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SMS Pharmaceuticals Ltd's reported carbon emissions
In 2024, SMS Pharmaceuticals Ltd reported total carbon emissions of approximately 37,382,480 kg CO2e from Scope 1, 42,378,970 kg CO2e from Scope 2, and 200,610 kg CO2e from Scope 3. This represents a significant increase in emissions compared to 2023, where the company recorded about 32,757,700 kg CO2e in Scope 1, 28,551,170 kg CO2e in Scope 2, and 31,870 kg CO2e in Scope 3. In 2022, the emissions were lower, with approximately 25,759,670 kg CO2e from Scope 1, 31,505,800 kg CO2e from Scope 2, and 32,500 kg CO2e from Scope 3. Despite the increase in emissions in 2024, SMS Pharmaceuticals has not publicly disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company continues to monitor and report its emissions across all three scopes, demonstrating a commitment to transparency in its environmental impact. As a pharmaceutical company headquartered in India, SMS Pharmaceuticals operates within an industry that is increasingly focused on sustainability and climate commitments, although specific pledges or targets have not been outlined in their recent reports.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 25,759,670 | 00,000,000 | 00,000,000 |
| Scope 2 | 31,505,800 | 00,000,000 | 00,000,000 |
| Scope 3 | 32,500 | 00,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SMS Pharmaceuticals Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
